Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

University of California San Diego, San Diego, California, United States

Sarcoma Oncology Center, Santa Monica, California, United States

Moffitt Cancer Center, Tampa, Florida, United States

University of Chicago, Chicago, Illinois, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

University of Pennsylvania, Philadelphia, Pennsylvania, United States

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

University of Texas - M.D. Anderson Cancer Center, Houston, Texas, United States

NEXT Oncology Houston, Houston, Texas, United States

NEXT Virginia, Fairfax, Virginia, United States

Hopital Saint - Andre - CHU de Bordeaux, Bordeaux, France

Centre Léon Bérard, Lyon, France

Hôpital de la Timone, Marseille, France

Hospital Universitario Vall d'Hebron, Barcelona, Spain

Hospital Universitario Ramón y Cajal, Madrid, Spain

START Madrid - Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

Hospital Universitario 12 de Octubre, Madrid, Spain

Hospital Clínico Universitario de Valencia, Valencia, Spain